• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Amgen (NQ: AMGN )

    316.91 -2.31 (-0.72%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Amgen

    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 20
    ...
    46 47 Next >
    Why Shares of Neumora Therapeutics Slumped This Week
    The clinical-stage biotech just had its IPO last week. 
    Via The Motley Fool
    Topics Initial Public Offering
    Exposures Securities Market
    2 Dividend Growth Stocks to Buy Right Now
    A wise man once said, be greedy when others are fearful. 
    Via The Motley Fool
    Check Out What Whales Are Doing With AMGN
    Via Benzinga
    Flee to Healthcare Stocks if Recession Rears its Head?
    In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
    Via MarketBeat
    Topics Economy
    Exposures Economy Interest Rates
    Amgen Unusual Options Activity
    Via Benzinga
    3 Quality Dividend Stocks For A Bear Market
    The potential for a recession means investors should focus on quality dividend stocks with strong yields. 
    Via Talk Markets
    Topics Economy
    Exposures Economy
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today
    Via Benzinga
    2 Top Dividend Stocks to Buy in September
    These two blue-chip dividend stocks have stood the test of time. 
    Via The Motley Fool
    How Is The Market Feeling About Amgen?
    Via Benzinga
    These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
    During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
    Via Benzinga
    The 3 Most Undervalued Biotech Stocks to Buy in September 2023
    While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners. 
    Via InvestorPlace
    Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
    Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
    Via Benzinga
    Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
    Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However,... 
    Via Benzinga
    3 Growth Stocks to Buy in September
    As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings 
    Via MarketBeat
    Topics Economy
    Exposures Economy
    8 Analysts Have This to Say About Amgen
    Via Benzinga
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
    Via Benzinga
    Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations
    On Friday, the U.S. 
    Via Benzinga
    Should You Still Buy the Dow Jones' Best-Performing August Stocks?
    They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture. 
    Via The Motley Fool
    Topics Stocks
    Exposures US Equities
    The 3 Most Promising Dow Stocks to Own Now
    The Dow market leaders got their heads handed to them in August. Here are three must-own Dow stocks to own for the long haul. 
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    8 Pharma Stocks Affected by New Drug Price Negotiation Rules
    Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs? 
    Via The Motley Fool
    Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review
    Tesla unveiled an updated Model 3, but also slashed Model S, X prices. 
    Via Investor's Business Daily
    Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal
    The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc (NASDAQ: HZNP).  
    Via Benzinga
    Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage
    The deal can now close in the fourth quarter. 
    Via Investor's Business Daily
    Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition
    From Horizon Therapeutics plc and Amgen
    Via Business Wire
    How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
    Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects. 
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Is This the Green Light Biotech Stocks Have Been Waiting For?
    It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics. 
    Via The Motley Fool
    What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
    Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations. 
    Via The Motley Fool
    Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
    To gain an edge, this is what you need to know today. 
    Via Benzinga
    Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
    The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including: 
    Via Benzinga
    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 20
    ...
    46 47 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.